The jury files back in to decide whether the treatment worked: the adenoma was removed, the colon got its procedural victory lap, and the invoice probably achieved sentience. Verdict? The polyp is gone. But according to a new study in Cell Host & Microbe, the gut microbiome may still be loitering...
Cancer genetics has changed AML care. Doctors already use mutations in genes like FLT3, IDH1, IDH2, NPM1, and CEBPA to help estimate risk and choose therapies. The 2022 European LeukemiaNet recommendations reflect how deeply genetics now shapes AML diagnosis and treatment planning [2].
Scientists got one big thing wrong about DNA repair: we treated it like the helpful cook who always saves dinner, when sometimes it grabs the wrong pot, burns the sauce, and sets off the smoke alarm.
What ingredient does a hungry breast tumor sometimes order before the chef even turns on the stove? Blood vessels.
Recipe for a treatment headache: take one colorectal cancer cell, add a KRAS G12C mutation, simmer with a targeted inhibitor, then watch the tumor rummage through the pantry for emergency escape ingredients. Some cells grab new mutations. Some change their personality. Some apparently pull the fire...
This paper describes a nanoparticle vaccine for HPV-related cervical disease. Then it casually turns that nanoparticle into a microscopic immune-system food truck with viral peptides, tumor membrane bits, and bacterial “please notice me” signals on the menu.
Fair question: do we really need artificial intelligence to stare at prostate biopsy slides, or is this just a very expensive way to say, “that looks bad”?
The road from ductal carcinoma in situ to invasive breast cancer has checkpoints, detours, and one suspicious-looking lane closure where the immune system keeps getting waved away.
The case opens with suspicious clues scattered across the cellular crime scene: a tumor burning sugar like it has a midnight deadline, mitochondria changing shape in the corner, immune cells looking oddly exhausted, and somewhere in the evidence locker, Otto Warburg’s ghost muttering, “I told you...
In the late-night reboot of Ocean's Eleven, the casino is your genome, the vault is gene expression, and the crew is made of tiny chemical tags sneaking onto histone proteins to decide which doors stay locked.
A 43-year-old woman with newly diagnosed triple-negative breast cancer sits in clinic, hears the words “aggressive” and “limited targets,” and immediately becomes fluent in the language of bad Tuesdays.
Level one of pancreatic cancer immunology looks simple: find the tumor boss, send in the immune warriors, collect victory loot. Then level two loads, the lights flicker, and you realize the boss arena is packed with suspicious support characters quietly locking doors, moving walls, and hiding all...
Leukemia stem cell: “We need runway.” Tumor metabolism: “Already shipped an internal ketone factory.” Ferroptosis: “Am I a joke to you?”
A ketone body helping leukemia stem cells survive sounds like the kind of sentence that deserves a raised eyebrow, a second opinion, and maybe a nurse quietly saying, “Okay, science, let’s not get cute.” But that is exactly the strange little doorway this new Cell Stem Cell paper opens.
Good immunotherapy is a little like making risotto: everyone talks about the rice, but the whole thing lives or dies by heat, timing, patience, and whether somebody wandered away to check their phone.
BRAF-mutant colorectal cancer is not the team you want to draw in round one. The BRAF V600E mutation shows up in roughly 10% of colorectal cancers, and it tends to come with a mean streak: faster progression, worse outcomes, and a nasty habit of shrugging off therapies that work better in other...
The cell has a supply chain, and in pancreatic cancer the package labeled "please show this to the immune system" seems to get intercepted before it reaches the loading dock.
Plant a garden long enough and you learn that the weeds were not always invaders from another planet. Some were sitting in the soil already, tiny and quiet, waiting for the wrong combination of rain, neglect, and cosmic bad luck to become everyone’s problem.
In The Last of Us, the scary part was fungi hijacking bodies; in gastric cancer, the scarier everyday version is tumor cells quietly convincing your immune system to act like it “didn’t see anything.”
Antibody-drug conjugates are often described as “smart chemotherapy,” which is mostly fair, though I prefer “chemo with a GPS and a tiny grudge.” Dato-DXd binds TROP2, a protein found on the surface of many epithelial cancers, including lung cancers. Once the antibody latches on, the whole package...